simbha

EXEL Long term .

做多
NASDAQ:EXEL   Exelixis, Inc.
IBB and XBI broke out.
Will EXEL follow the sector trend with an excellent clinical read outs across multiple oncology fields?
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。